| 000 | 01785 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250513211715.0 | ||
| 264 | 0 | _c20000720 | |
| 008 | 200007s 0 0 eng d | ||
| 022 | _a0022-1899 | ||
| 024 | 7 |
_a10.1086/315462 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTaylor, D N | |
| 245 | 0 | 0 |
_aTwo-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in Peru. _h[electronic resource] |
| 260 |
_bThe Journal of infectious diseases _cMay 2000 |
||
| 300 |
_a1667-73 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aCholera _xepidemiology |
| 650 | 0 | 4 |
_aCholera Toxin _xadministration & dosage |
| 650 | 0 | 4 |
_aCholera Vaccines _xadministration & dosage |
| 650 | 0 | 4 |
_aDiarrhea _xvirology |
| 650 | 0 | 4 |
_aFeces _xmicrobiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPeru _xepidemiology |
| 650 | 0 | 4 | _aPopulation Surveillance |
| 650 | 0 | 4 |
_aVaccines, Synthetic _xadministration & dosage |
| 650 | 0 | 4 |
_aVibrio cholerae _ximmunology |
| 650 | 0 | 4 | _aVirus Shedding |
| 700 | 1 | _aCárdenas, V | |
| 700 | 1 | _aSanchez, J L | |
| 700 | 1 | _aBégué, R E | |
| 700 | 1 | _aGilman, R | |
| 700 | 1 | _aBautista, C | |
| 700 | 1 | _aPerez, J | |
| 700 | 1 | _aPuga, R | |
| 700 | 1 | _aGaillour, A | |
| 700 | 1 | _aMeza, R | |
| 700 | 1 | _aEcheverria, P | |
| 700 | 1 | _aSadoff, J | |
| 773 | 0 |
_tThe Journal of infectious diseases _gvol. 181 _gno. 5 _gp. 1667-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1086/315462 _zAvailable from publisher's website |
| 999 |
_c10775364 _d10775364 |
||